JZP-815: payments to doctors
Payments that named JZP-815 as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $14K
- Providers
- 4
- Transactions
- 4
- Average per transaction
- $3,500
The per-transaction average — $3,500 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4 providers the average total is $3,500, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| JAZZ Pharmaceuticals Inc. | $14,000 | 100.0% |